BMI's relation to cancer therapy mortality risks not so straightforward, study finds

byOsaka Metropolitan UniversityFor non-small cell lung cancer treatment, immunotherapy seems to pose less risk for persons under a certain BMI, while conventional chemotherapy appears optimal fo

Oncology September 27,2024 0

BMI's relation to cancer therapy mortality risks not so straightforward, study finds

byOsaka Metropolitan UniversityFor non-small cell lung cancer treatment, immunotherapy seems to pose less risk for persons under a certain BMI, while conventional chemotherapy appears optimal fo

Oncology September 27,2024 0

AI tool reveals cardiac risk for patients undergoing cancer therapy

byYale School of MedicineBaseline AI-ECG screening for LVSD and all-cause mortality risk. Adjusted cumulative hazard curves for all-cause mortality stratified by the AI-ECG LVSD probability. Cre

Cardiology & Vascular surgery September 27,2024 0

AI tool reveals cardiac risk for patients undergoing cancer therapy

byYale School of MedicineBaseline AI-ECG screening for LVSD and all-cause mortality risk. Adjusted cumulative hazard curves for all-cause mortality stratified by the AI-ECG LVSD probability. Cre

Cardiology & Vascular surgery September 27,2024 0

Men often confused about prostate cancer screening, survey shows

by Ernie MundellA new survey finds the majority of American men believe the first step inprostate cancerscreening is an invasive rectal exam by their doctor.That's not true, but mistak

Nephrology & Urology September 27,2024 0

Men often confused about prostate cancer screening, survey shows

by Ernie MundellA new survey finds the majority of American men believe the first step inprostate cancerscreening is an invasive rectal exam by their doctor.That's not true, but mistak

Nephrology & Urology September 27,2024 0

Osimertinib with savolitinib demonstrates stronger efficacy than osimertinib alone in some patients

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response

Oncology September 27,2024 0

Osimertinib with savolitinib demonstrates stronger efficacy than osimertinib alone in some patients

by International Association for the Study of Lung CancerCredit: Unsplash/CC0 Public DomainThe combination of osimertinib and savolitinib showed clinically meaningful improvement in objective response

Oncology September 27,2024 0

Pathway tied to cancer-driving genome alterations identified

byUTSouthwestern Medical CenterThese images show examples of mitotic chromosome spreads from human cancer cells containing a shattered chromosome (left panel) or extrachromosomal DNA (midd

Oncology September 27,2024 0

Pathway tied to cancer-driving genome alterations identified

byUTSouthwestern Medical CenterThese images show examples of mitotic chromosome spreads from human cancer cells containing a shattered chromosome (left panel) or extrachromosomal DNA (midd

Oncology September 27,2024 0

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Oncology September 27,2024 0

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Oncology September 27,2024 0

Can chatbots help with genetic testing for cancer risk?

byHuntsman Cancer InstituteCredit: CC0 Public DomainIn a study from Huntsman Cancer Institute at the University of Utah (the U) and NYU Langone Perlmutter Cancer Center, researchers found that a

Oncology September 27,2024 0

Can chatbots help with genetic testing for cancer risk?

byHuntsman Cancer InstituteCredit: CC0 Public DomainIn a study from Huntsman Cancer Institute at the University of Utah (the U) and NYU Langone Perlmutter Cancer Center, researchers found that a

Oncology September 27,2024 0

Sweden sees skin cancer decline in under-50s for 1st time: Study

Credit: Anna Tarazevich from PexelsSkin cancer is declining among younger adults in Sweden for the first time after decades of increases, making it the first European country to see a fall, researcher

Dermatology September 27,2024 0

Sweden sees skin cancer decline in under-50s for 1st time: Study

Credit: Anna Tarazevich from PexelsSkin cancer is declining among younger adults in Sweden for the first time after decades of increases, making it the first European country to see a fall, researcher

Dermatology September 27,2024 0

Spaceflight Challenges: Health Risks for Astronauts and Extended ISS Missions

Cardiology & Vascular surgery September 25,2024 0

Spaceflight Challenges: Health Risks for Astronauts and Extended ISS Missions

Cardiology & Vascular surgery September 25,2024 0

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the

Oncology September 25,2024 0

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the

Oncology September 25,2024 0